Cargando…
Difluoromethyl-1,3,4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity
Histone deacetylase 6 (HDAC6) is an attractive drug development target because of its role in the immune response, neuropathy, and cancer. Knockout mice develop normally and have no apparent phenotype, suggesting that selective inhibitors should have an excellent therapeutic window. Unfortunately, c...
Autores principales: | Cellupica, Edoardo, Caprini, Gianluca, Cordella, Paola, Cukier, Cyprian, Fossati, Gianluca, Marchini, Mattia, Rocchio, Ilaria, Sandrone, Giovanni, Vanoni, Maria Antonietta, Vergani, Barbara, Źrubek, Karol, Stevenazzi, Andrea, Steinkühler, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860109/ https://www.ncbi.nlm.nih.gov/pubmed/36528061 http://dx.doi.org/10.1016/j.jbc.2022.102800 |
Ejemplares similares
-
The Importance of the “Time Factor” for the Evaluation of Inhibition Mechanisms: The Case of Selected HDAC6 Inhibitors
por: Cellupica, Edoardo, et al.
Publicado: (2023) -
HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19
por: Ripamonti, Chiara, et al.
Publicado: (2022) -
Role of condensates in modulating DNA repair pathways and its implication for chemoresistance
por: Dall’Agnese, Giuseppe, et al.
Publicado: (2023) -
Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives
por: Glomb, Teresa, et al.
Publicado: (2021) -
5-Phenyl-1,3,4-oxadiazol-2-amine
por: Song, Man-Man, et al.
Publicado: (2012)